DPP4 and diabetes mellitus: Dipeptidyl peptidase 4 (DPP4) inhibitors, also known as gliptins, are a class of oral hypoglycemic drugs that block the enzyme DPP4 and can be used to treat diabetes mellitus type 2 (DM‐II).